Eligibility Criteria Intro 2019

Moderator: Gwynn Ison, MD; U.S. Food and Drug  Administration Panel Discussion Edward Kim, MD; Levine Cancer Institute Performance Status Elizabeth Garrett-Mayer, PhD; American Society of Clinical Oncology Harpreet Singh, MD; U.S. Food and Drug Administration Drug Washout/Con Meds Vishal Bhatnagar, MD; U.S. Food and Drug Administration Scot Ebbinghaus, MD; Merck Prior Therapies Read more…